-
1
-
-
0034796387
-
A history of influenza
-
Potter CW (2001) A history of influenza. J Appl Microbiol 91(4): 572-579.
-
(2001)
J Appl Microbiol
, vol.91
, Issue.4
, pp. 572-579
-
-
Potter, C.W.1
-
2
-
-
34249938743
-
The annual impact of seasonal influenza in the US: measuring disease burden and costs
-
doi:10.1016/j.vaccine.2007.03.046
-
Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25(27): 5086-5096. doi: 10. 1016/j. vaccine. 2007. 03. 046.
-
(2007)
Vaccine
, vol.25
, Issue.27
, pp. 5086-5096
-
-
Molinari, N.A.1
Ortega-Sanchez, I.R.2
Messonnier, M.L.3
Thompson, W.W.4
Wortley, P.M.5
Weintraub, E.6
Bridges, C.B.7
-
3
-
-
67651083650
-
Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza
-
doi:10.1016/j.vaccine.2009.06.034
-
Collin N, de Radigues X (2009) Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27(38): 5184-5186. doi: 10. 1016/j. vaccine. 2009. 06. 034.
-
(2009)
Vaccine
, vol.27
, Issue.38
, pp. 5184-5186
-
-
Collin, N.1
de Radigues, X.2
-
5
-
-
0019997609
-
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
-
doi:10.1056/NEJM198209023071002
-
Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J (1982) A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New Engl J Med 307(10): 580-584. doi: 10. 1056/NEJM198209023071002.
-
(1982)
New Engl J Med
, vol.307
, Issue.10
, pp. 580-584
-
-
Dolin, R.1
Reichman, R.C.2
Madore, H.P.3
Maynard, R.4
Linton, P.N.5
Webber-Jones, J.6
-
6
-
-
79956007117
-
Systematic review of influenza resistance to the neuraminidase inhibitors
-
doi:10.1186/1471-2334-11-134
-
Thorlund K, Awad T, Boivin G, Thabane L (2011) Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis 11: 134. doi: 10. 1186/1471-2334-11-134.
-
(2011)
BMC Infect Dis
, vol.11
, pp. 134
-
-
Thorlund, K.1
Awad, T.2
Boivin, G.3
Thabane, L.4
-
7
-
-
79952217106
-
Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the advisory committee on immunization practices (ACIP)
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention (2011) Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 60(1): 1-24.
-
(2011)
MMWR Recomm Rep
, vol.60
, Issue.1
, pp. 1-24
-
-
-
8
-
-
0016272701
-
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase
-
Palese P, Tobita K, Ueda M, Compans RW (1974) Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61(2): 397-410.
-
(1974)
Virology
, vol.61
, Issue.2
, pp. 397-410
-
-
Palese, P.1
Tobita, K.2
Ueda, M.3
Compans, R.W.4
-
9
-
-
7644241814
-
Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium
-
2667.2004, doi:10.1128/JVI.78.22.12665-1
-
Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD (2004) Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78(22): 12665-12667. doi: 10. 1128/JVI. 78. 22. 12665-1 2667. 2004.
-
(2004)
J Virol
, vol.78
, Issue.22
, pp. 12665-12667
-
-
Matrosovich, M.N.1
Matrosovich, T.Y.2
Gray, T.3
Roberts, N.A.4
Klenk, H.D.5
-
10
-
-
36749056771
-
The war against influenza: discovery and development of sialidase inhibitors
-
von Itzstein M (2007) The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov 6(12): 967-974.
-
(2007)
Nat Rev Drug Discov
, vol.6
, Issue.12
, pp. 967-974
-
-
von Itzstein, M.1
-
11
-
-
9844220300
-
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group
-
doi:10.1056/NEJM199709253371302
-
Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K (1997) Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group. New Engl J Med 337(13): 874-880. doi: 10. 1056/NEJM199709253371302.
-
(1997)
New Engl J Med
, vol.337
, Issue.13
, pp. 874-880
-
-
Hayden, F.G.1
Osterhaus, A.D.2
Treanor, J.J.3
Fleming, D.M.4
Aoki, F.Y.5
Nicholson, K.G.6
Bohnen, A.M.7
Hirst, H.M.8
Keene, O.9
Wightman, K.10
-
12
-
-
0033530264
-
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment
-
Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE (1999) Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282(13): 1240-1246.
-
(1999)
Jama
, vol.282
, Issue.13
, pp. 1240-1246
-
-
Hayden, F.G.1
Treanor, J.J.2
Fritz, R.S.3
Lobo, M.4
Betts, R.F.5
Miller, M.6
Kinnersley, N.7
Mills, R.G.8
Ward, P.9
Straus, S.E.10
-
13
-
-
0141501525
-
Clinical benefits with oseltamivir in treating influenza in adult populations: results of a pooled and subgroup analysis
-
Singh S, Barghoorn J, Bagdonas A, Adler J, Treanor J, Kinnersley N, Ward P (2003) Clinical benefits with oseltamivir in treating influenza in adult populations: results of a pooled and subgroup analysis. Clin Drug Investig 23(9): 561-569.
-
(2003)
Clin Drug Investig
, vol.23
, Issue.9
, pp. 561-569
-
-
Singh, S.1
Barghoorn, J.2
Bagdonas, A.3
Adler, J.4
Treanor, J.5
Kinnersley, N.6
Ward, P.7
-
14
-
-
17744412173
-
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial
-
Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG (2000) Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 283(8): 1016-1024.
-
(2000)
Jama
, vol.283
, Issue.8
, pp. 1016-1024
-
-
Treanor, J.J.1
Hayden, F.G.2
Vrooman, P.S.3
Barbarash, R.4
Bettis, R.5
Riff, D.6
Singh, S.7
Kinnersley, N.8
Ward, P.9
Mills, R.G.10
-
15
-
-
0034720503
-
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group
-
Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P (2000) Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 355(9218): 1845-1850.
-
(2000)
Lancet
, vol.355
, Issue.9218
, pp. 1845-1850
-
-
Nicholson, K.G.1
Aoki, F.Y.2
Osterhaus, A.D.3
Trottier, S.4
Carewicz, O.5
Mercier, C.H.6
Rode, A.7
Kinnersley, N.8
Ward, P.9
-
16
-
-
77953517101
-
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance
-
doi:10.1093/jac/dkq100
-
Moss RB, Davey RT, Steigbigel RT, Fang F (2010) Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. J Antimicrob Chemother 65(6): 1086-1093. doi: 10. 1093/jac/dkq100.
-
(2010)
J Antimicrob Chemother
, vol.65
, Issue.6
, pp. 1086-1093
-
-
Moss, R.B.1
Davey, R.T.2
Steigbigel, R.T.3
Fang, F.4
-
17
-
-
33745635392
-
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
-
doi:10.1128/AAC.01339-05
-
Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50(7): 2395-2402. doi: 10. 1128/AAC. 01339-05.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, Issue.7
, pp. 2395-2402
-
-
Monto, A.S.1
McKimm-Breschkin, J.L.2
Macken, C.3
Hampson, A.W.4
Hay, A.5
Klimov, A.6
Tashiro, M.7
Webster, R.G.8
Aymard, M.9
Hayden, F.G.10
Zambon, M.11
-
18
-
-
40549111528
-
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe
-
Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC (2008) Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 13(5).
-
(2008)
Euro surveillance: Bulletin europeen sur les maladies transmissibles = European communicable disease bulletin
, vol.13
, Issue.5
-
-
Lackenby, A.1
Hungnes, O.2
Dudman, S.G.3
Meijer, A.4
Paget, W.J.5
Hay, A.J.6
Zambon, M.C.7
-
19
-
-
62349105166
-
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08
-
Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 15(2): 155-162.
-
(2009)
Emerg Infect Dis
, vol.15
, Issue.2
, pp. 155-162
-
-
Hauge, S.H.1
Dudman, S.2
Borgen, K.3
Lackenby, A.4
Hungnes, O.5
-
20
-
-
65149097183
-
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season
-
doi:10.3201/eid1504.181280
-
Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schweiger B, Opp M, Paget J, van de Kassteele J, Hay A, Zambon M (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 15(4): 552-560. doi: 10. 3201/eid1504. 181280.
-
(2009)
Emerg Infect Dis
, vol.15
, Issue.4
, pp. 552-560
-
-
Meijer, A.1
Lackenby, A.2
Hungnes, O.3
Lina, B.4
van der Werf, S.5
Schweiger, B.6
Opp, M.7
Paget, J.8
van de Kassteele, J.9
Hay, A.10
Zambon, M.11
-
21
-
-
0036294323
-
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
-
Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA (2002) The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res 55(2): 307-317.
-
(2002)
Antiviral Res
, vol.55
, Issue.2
, pp. 307-317
-
-
Ives, J.A.1
Carr, J.A.2
Mendel, D.B.3
Tai, C.Y.4
Lambkin, R.5
Kelly, L.6
Oxford, J.S.7
Hayden, F.G.8
Roberts, N.A.9
-
22
-
-
77953262416
-
Permissive secondary mutations enable the evolution of influenza oseltamivir resistance
-
doi:10.1126/science.1187816
-
Bloom JD, Gong LI, Baltimore D (2010) Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328(5983): 1272-1275. doi: 10. 1126/science. 1187816.
-
(2010)
Science
, vol.328
, Issue.5983
, pp. 1272-1275
-
-
Bloom, J.D.1
Gong, L.I.2
Baltimore, D.3
-
23
-
-
79953315201
-
Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009
-
doi:10.1371/journal.pone.0018177
-
Yang JR, Lin YC, Huang YP, Su CH, Lo J, Ho YL, Yao CY, Hsu LC, Wu HS, Liu MT (2011) Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009. PloS one 6(3): e18177. doi: 10. 1371/journal. pone. 0018177.
-
(2011)
PloS One
, vol.6
, Issue.3
-
-
Yang, J.R.1
Lin, Y.C.2
Huang, Y.P.3
Su, C.H.4
Lo, J.5
Ho, Y.L.6
Yao, C.Y.7
Hsu, L.C.8
Wu, H.S.9
Liu, M.T.10
-
24
-
-
78650978283
-
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro
-
doi:10.3851/IMP1678
-
Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI (2010) Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antiv Ther 15(8): 1151-1159. doi: 10. 3851/IMP1678.
-
(2010)
Antiv Ther
, vol.15
, Issue.8
, pp. 1151-1159
-
-
Gubareva, L.V.1
Trujillo, A.A.2
Okomo-Adhiambo, M.3
Mishin, V.P.4
Deyde, V.M.5
Sleeman, K.6
Nguyen, H.T.7
Sheu, T.G.8
Garten, R.J.9
Shaw, M.W.10
Fry, A.M.11
Klimov, A.I.12
-
25
-
-
79551650598
-
Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States
-
doi:10.3201/eid1702.101724
-
Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, Waters C, Moore Z, Sleeman K, Okomo-Adhiambo M, Marshall SA, St George K, Pan CY, LaPlante JM, Klimov A, Fry AM (2011) Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis 17(2): 255-257. doi: 10. 3201/eid1702. 101724.
-
(2011)
Emerg Infect Dis
, vol.17
, Issue.2
, pp. 255-257
-
-
Graitcer, S.B.1
Gubareva, L.2
Kamimoto, L.3
Doshi, S.4
Vandermeer, M.5
Louie, J.6
Waters, C.7
Moore, Z.8
Sleeman, K.9
Okomo-Adhiambo, M.10
Marshall, S.A.11
St George, K.12
Pan, C.Y.13
LaPlante, J.M.14
Klimov, A.15
Fry, A.M.16
-
28
-
-
73949134239
-
Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong
-
doi:10.3201/eid1512.091057
-
Chen H, Cheung CL, Tai H, Zhao P, Chan JF, Cheng VC, Chan KH, Yuen KY (2009) Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong. China. Emerg Infect Dis 15(12): 1970-1972. doi: 10. 3201/eid1512. 091057.
-
(2009)
China. Emerg Infect Dis
, vol.15
, Issue.12
, pp. 1970-1972
-
-
Chen, H.1
Cheung, C.L.2
Tai, H.3
Zhao, P.4
Chan, J.F.5
Cheng, V.C.6
Chan, K.H.7
Yuen, K.Y.8
-
29
-
-
84856325057
-
Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11
-
doi:10.3201/eid1802.111466
-
Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM (2012) Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11. Emerg Infect Dis 18(2): 308-311. doi: 10. 3201/eid1802. 111466.
-
(2012)
Emerg Infect Dis
, vol.18
, Issue.2
, pp. 308-311
-
-
Storms, A.D.1
Gubareva, L.V.2
Su, S.3
Wheeling, J.T.4
Okomo-Adhiambo, M.5
Pan, C.Y.6
Reisdorf, E.7
St George, K.8
Myers, R.9
Wotton, J.T.10
Robinson, S.11
Leader, B.12
Thompson, M.13
Shannon, M.14
Klimov, A.15
Fry, A.M.16
-
30
-
-
84862902952
-
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia
-
doi:10.1093/infdis/jis337
-
Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG (2012) Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 206(2): 148-157. doi: 10. 1093/infdis/jis337.
-
(2012)
J Infect Dis
, vol.206
, Issue.2
, pp. 148-157
-
-
Hurt, A.C.1
Hardie, K.2
Wilson, N.J.3
Deng, Y.M.4
Osbourn, M.5
Leang, S.K.6
Lee, R.T.7
Iannello, P.8
Gehrig, N.9
Shaw, R.10
Wark, P.11
Caldwell, N.12
Givney, R.C.13
Xue, L.14
Maurer-Stroh, S.15
Dwyer, D.E.16
Wang, B.17
Smith, D.W.18
Levy, A.19
Booy, R.20
Dixit, R.21
Merritt, T.22
Kelso, A.23
Dalton, C.24
Durrheim, D.25
Barr, I.G.26
more..
-
31
-
-
74949097490
-
A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
-
doi:10.1056/NEJMc0910732
-
Mai LQ, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P (2010) A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 362(1): 86-87. doi: 10. 1056/NEJMc0910732.
-
(2010)
N Engl J Med
, vol.362
, Issue.1
, pp. 86-87
-
-
Mai, L.Q.1
Wertheim, H.F.2
Tran, N.D.3
van Doorn, H.R.4
Nguyen, T.H.5
Horby, P.6
-
32
-
-
79952328206
-
Wolfe CR (2011) Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients-North Carolina
-
doi:10.1093/infdis/jiq124
-
Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS, Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A (2009) Wolfe CR (2011) Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients-North Carolina. J Infect Dis 203(6): 838-846. doi: 10. 1093/infdis/jiq124.
-
(2009)
J Infect Dis
, vol.203
, Issue.6
, pp. 838-846
-
-
Chen, L.F.1
Dailey, N.J.2
Rao, A.K.3
Fleischauer, A.T.4
Greenwald, I.5
Deyde, V.M.6
Moore, Z.S.7
Anderson, D.J.8
Duffy, J.9
Gubareva, L.V.10
Sexton, D.J.11
Fry, A.M.12
Srinivasan, A.13
-
33
-
-
0029867750
-
Combination antiviral therapy for respiratory virus infections
-
Hayden FG (1996) Combination antiviral therapy for respiratory virus infections. Antiviral Res 29(1): 45-48.
-
(1996)
Antiviral Res
, vol.29
, Issue.1
, pp. 45-48
-
-
Hayden, F.G.1
-
34
-
-
65549113423
-
Influenza virus resistance to antiviral agents: a plea for rational use
-
doi:10.1086/598989
-
Poland GA, Jacobson RM, Ovsyannikova IG (2009) Influenza virus resistance to antiviral agents: a plea for rational use. Clin Infect Dis 48(9): 1254-1256. doi: 10. 1086/598989.
-
(2009)
Clin Infect Dis
, vol.48
, Issue.9
, pp. 1254-1256
-
-
Poland, G.A.1
Jacobson, R.M.2
Ovsyannikova, I.G.3
-
35
-
-
84902000712
-
-
1st edn., USA: Oxford University Press
-
Zuniga JM, Whiteside A, Ghaziani A, Bartlett JG (2008) A decade of HAART: the development and global impact of highly active antiretroviral therapy, 1st edn. Oxford University Press, USA.
-
(2008)
A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy
-
-
Zuniga, J.M.1
Whiteside, A.2
Ghaziani, A.3
Bartlett, J.G.4
-
36
-
-
84875043423
-
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis
-
doi:10.1093/cid/cis1031
-
Druyts E, Thorlund K, Wu P, Kanters S, Yaya S, Cooper CL, Mills EJ (2012) Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis. Clin Infect Dis. doi: 10. 1093/cid/cis1031.
-
(2012)
Clin Infect Dis
-
-
Druyts, E.1
Thorlund, K.2
Wu, P.3
Kanters, S.4
Yaya, S.5
Cooper, C.L.6
Mills, E.J.7
-
37
-
-
0019198751
-
Enhancement of activity against influenza viruses by combinations of antiviral agents
-
Hayden FG, Douglas RG Jr, Simons R (1980) Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother 18(4): 536-541.
-
(1980)
Antimicrob Agents Chemother
, vol.18
, Issue.4
, pp. 536-541
-
-
Hayden, F.G.1
Douglas Jr., R.G.2
Simons, R.3
-
38
-
-
0028932874
-
In vitro inhibitory effects of combinations of anti-influenza agents
-
Madren LK, Shipman C, Hayden FG (1995) In vitro inhibitory effects of combinations of anti-influenza agents. Antiviral Chem Chemother 6(2): 109-113.
-
(1995)
Antiviral Chem Chemother
, vol.6
, Issue.2
, pp. 109-113
-
-
Madren, L.K.1
Shipman, C.2
Hayden, F.G.3
-
39
-
-
9644262504
-
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells
-
doi:10.1128/AAC.48.12.4855-4863.2004
-
Govorkova EA, Fang HB, Tan M, Webster RG (2004) Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob Agents Chemother 48(12): 4855-4863. doi: 10. 1128/AAC. 48. 12. 4855-4863. 2004.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, Issue.12
, pp. 4855-4863
-
-
Govorkova, E.A.1
Fang, H.B.2
Tan, M.3
Webster, R.G.4
-
40
-
-
70349331605
-
Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro
-
doi:10.1128/AAC.00476-09
-
Nguyen JT, Hoopes JD, Smee DF, Prichard MN, Driebe EM, Engelthaler DM, Le MH, Keim PS, Spence RP, Went GT (2009) Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 53(10): 4115-4126. doi: 10. 1128/AAC. 00476-09.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, Issue.10
, pp. 4115-4126
-
-
Nguyen, J.T.1
Hoopes, J.D.2
Smee, D.F.3
Prichard, M.N.4
Driebe, E.M.5
Engelthaler, D.M.6
Le, M.H.7
Keim, P.S.8
Spence, R.P.9
Went, G.T.10
-
41
-
-
84859053626
-
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
-
doi:10.1016/j.antiviral.2012.03.001
-
Tarbet EB, Maekawa M, Furuta Y, Babu YS, Morrey JD, Smee DF (2012) Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice. Antiviral Res 94(1): 103-110. doi: 10. 1016/j. antiviral. 2012. 03. 001.
-
(2012)
Antiviral Res
, vol.94
, Issue.1
, pp. 103-110
-
-
Tarbet, E.B.1
Maekawa, M.2
Furuta, Y.3
Babu, Y.S.4
Morrey, J.D.5
Smee, D.F.6
-
42
-
-
0018840131
-
Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice
-
Wilson SZ, Knight V, Wyde PR, Drake S, Couch RB (1980) Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob Agents Chemother 17(4): 642-648.
-
(1980)
Antimicrob Agents Chemother
, vol.17
, Issue.4
, pp. 642-648
-
-
Wilson, S.Z.1
Knight, V.2
Wyde, P.R.3
Drake, S.4
Couch, R.B.5
-
43
-
-
34249001427
-
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice
-
Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA (2007) Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antiviral therapy 12(3): 363-370.
-
(2007)
Antiviral Therapy
, vol.12
, Issue.3
, pp. 363-370
-
-
Ilyushina, N.A.1
Hoffmann, E.2
Salomon, R.3
Webster, R.G.4
Govorkova, E.A.5
-
44
-
-
55849102109
-
Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice
-
doi:10.1128/AAC.01579-07
-
Ilyushina NA, Hay A, Yilmaz N, Boon AC, Webster RG, Govorkova EA (2008) Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother 52(11): 3889-3897. doi: 10. 1128/AAC. 01579-07.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, Issue.11
, pp. 3889-3897
-
-
Ilyushina, N.A.1
Hay, A.2
Yilmaz, N.3
Boon, A.C.4
Webster, R.G.5
Govorkova, E.A.6
-
45
-
-
84856078603
-
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses
-
doi:10.1371/journal.pone.0031006
-
Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, de Jong MD, Went GT (2012) Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PloS One 7(1): e31006. doi: 10. 1371/journal. pone. 0031006.
-
(2012)
PloS One
, vol.7
, Issue.1
-
-
Nguyen, J.T.1
Smee, D.F.2
Barnard, D.L.3
Julander, J.G.4
Gross, M.5
de Jong, M.D.6
Went, G.T.7
-
46
-
-
64749093901
-
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
-
doi:10.1016/j.antiviral.2009.02.198
-
Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, Gowen BB, Julander JG, Morrey JD (2009) T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res 82(3): 95-102. doi: 10. 1016/j. antiviral. 2009. 02. 198.
-
(2009)
Antiviral Res
, vol.82
, Issue.3
, pp. 95-102
-
-
Furuta, Y.1
Takahashi, K.2
Shiraki, K.3
Sakamoto, K.4
Smee, D.F.5
Barnard, D.L.6
Gowen, B.B.7
Julander, J.G.8
Morrey, J.D.9
-
48
-
-
0024993530
-
A three-dimensional model to analyze drug-drug interactions
-
Prichard MN, Shipman C Jr (1990) A three-dimensional model to analyze drug-drug interactions. Antiviral Res 14(4-5): 181-205.
-
(1990)
Antiviral Res
, vol.14
, Issue.4-5
, pp. 181-205
-
-
Prichard, M.N.1
Shipman Jr., C.2
-
49
-
-
0035115174
-
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
-
doi:10.1128/AAC.45.3.743-748.2001
-
Smee DF, Huffman JH, Morrison AC, Barnard DL, Sidwell RW (2001) Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother 45(3): 743-748. doi: 10. 1128/AAC. 45. 3. 743-748. 2001.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, Issue.3
, pp. 743-748
-
-
Smee, D.F.1
Huffman, J.H.2
Morrison, A.C.3
Barnard, D.L.4
Sidwell, R.W.5
-
50
-
-
33745158157
-
A simple method of estimating fifty perent endpoints
-
Reed LJ, Muench H (1938) A simple method of estimating fifty perent endpoints. Am J Hyg 27(3): 493-497.
-
(1938)
Am J Hyg
, vol.27
, Issue.3
, pp. 493-497
-
-
Reed, L.J.1
Muench, H.2
-
51
-
-
84946384873
-
The toxicity of poisons applied jointly
-
Bliss CI (1939) The toxicity of poisons applied jointly. Ann Appl Biol 26(3): 585-615.
-
(1939)
Ann Appl Biol
, vol.26
, Issue.3
, pp. 585-615
-
-
Bliss, C.I.1
-
53
-
-
73849083795
-
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice
-
doi:10.1128/AAC.00933-09
-
Smee DF, Hurst BL, Wong MH, Bailey KW, Tarbet EB, Morrey JD, Furuta Y (2010) Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice. Antimicrob Agents Chemother 54(1): 126-133. doi: 10. 1128/AAC. 00933-09.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.1
, pp. 126-133
-
-
Smee, D.F.1
Hurst, B.L.2
Wong, M.H.3
Bailey, K.W.4
Tarbet, E.B.5
Morrey, J.D.6
Furuta, Y.7
-
54
-
-
77952645453
-
In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses
-
doi:10.1128/AAC.01739-09
-
Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV (2010) In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob Agents Chemother 54(6): 2517-2524. doi: 10. 1128/AAC. 01739-09.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.6
, pp. 2517-2524
-
-
Sleeman, K.1
Mishin, V.P.2
Deyde, V.M.3
Furuta, Y.4
Klimov, A.I.5
Gubareva, L.V.6
-
55
-
-
0033961667
-
Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
-
Tisdale M (2000) Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors. Rev Med Virol 10(1): 45-55.
-
(2000)
Rev Med Virol
, vol.10
, Issue.1
, pp. 45-55
-
-
Tisdale, M.1
-
56
-
-
33646784370
-
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
-
doi:10.1016/j.antiviral.2006.01.012
-
Ilyushina NA, Bovin NV, Webster RG, Govorkova EA (2006) Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antiviral Res 70(3): 121-131. doi: 10. 1016/j. antiviral. 2006. 01. 012.
-
(2006)
Antiviral Res
, vol.70
, Issue.3
, pp. 121-131
-
-
Ilyushina, N.A.1
Bovin, N.V.2
Webster, R.G.3
Govorkova, E.A.4
-
57
-
-
84855261948
-
Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus
-
doi:10.1371/journal.pone.0029778
-
Hoopes JD, Driebe EM, Kelley E, Engelthaler DM, Keim PS, Perelson AS, Rong L, Went GT, Nguyen JT (2011) Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus. PloS One 6(12): e29778. doi: 10. 1371/journal. pone. 0029778.
-
(2011)
PloS One
, vol.6
, Issue.12
-
-
Hoopes, J.D.1
Driebe, E.M.2
Kelley, E.3
Engelthaler, D.M.4
Keim, P.S.5
Perelson, A.S.6
Rong, L.7
Went, G.T.8
Nguyen, J.T.9
-
58
-
-
0017652246
-
Combined action of ribovirin and rimantadine in experimental myxovirus infection
-
doi:10.1007/Bf01951273
-
Galegov GA, Pushkarskaya NL, Obrosovaserova NP, Zhdanov VM (1977) Combined action of ribovirin and rimantadine in experimental myxovirus infection. Experientia 33(7): 905-906. doi: 10. 1007/Bf01951273.
-
(1977)
Experientia
, vol.33
, Issue.7
, pp. 905-906
-
-
Galegov, G.A.1
Pushkarskaya, N.L.2
Obrosovaserova, N.P.3
Zhdanov, V.M.4
-
59
-
-
0023030837
-
Combinations of antiviral agents for treatment of influenza virus infections
-
Hayden FG (1986) Combinations of antiviral agents for treatment of influenza virus infections. J Antimicrob Chemother 18 Suppl B: 177-183.
-
(1986)
J Antimicrob Chemother
, vol.18
, Issue.SUPPL B
, pp. 177-183
-
-
Hayden, F.G.1
-
60
-
-
78649911852
-
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial
-
doi:10.1371/journal.pmed.1000362
-
Duval X, van der Werf S, Blanchon T, Mosnier A, Bouscambert-Duchamp M, Tibi A, Enouf V, Charlois-Ou C, Vincent C, Andreoletti L, Tubach F, Lina B, Mentre F, Leport C (2010) Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med 7(11): e1000362. doi: 10. 1371/journal. pmed. 1000362.
-
(2010)
PLoS Med
, vol.7
, Issue.11
-
-
Duval, X.1
van der Werf, S.2
Blanchon, T.3
Mosnier, A.4
Bouscambert-Duchamp, M.5
Tibi, A.6
Enouf, V.7
Charlois-Ou, C.8
Vincent, C.9
Andreoletti, L.10
Tubach, F.11
Lina, B.12
Mentre, F.13
Leport, C.14
-
61
-
-
14744274674
-
Mechanism of action of T-705 against influenza virus
-
doi:10.1128/AAC.49.3.981-986.2005
-
Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, Nomura N, Egawa H, Shiraki K (2005) Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother 49(3): 981-986. doi: 10. 1128/AAC. 49. 3. 981-986. 2005.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, Issue.3
, pp. 981-986
-
-
Furuta, Y.1
Takahashi, K.2
Kuno-Maekawa, M.3
Sangawa, H.4
Uehara, S.5
Kozaki, K.6
Nomura, N.7
Egawa, H.8
Shiraki, K.9
|